Corpus Intelligence IC Memo — UBH OF PHOENIX LLC DBA VALLEY HSP 2026-04-26 05:26 UTC
IC Memo — UBH OF PHOENIX LLC DBA VALLEY HSP
Investment Committee Memorandum | AZ | 122 beds | Grade D | EBITDA uplift $6.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UBH OF PHOENIX LLC DBA VALLEY HSP

CCN 034026 | MARICOPA, AZ | 122 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

UBH OF PHOENIX LLC DBA VALLEY HSP is a 122-bed community hospital in MARICOPA, AZ with $86.7M in net patient revenue and a 61.3% operating margin. The hospital serves a payer mix of 8.8% Medicare, 0.0% Medicaid, and 91.2% commercial.

Thesis: Turnaround. Our ML models identify $6.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 61.3% to 68.6% (+736bps).

Net Revenue HCRIS$86.7M
Current EBITDA COMPUTED$53.1M
Operating Margin COMPUTED61.3%
Occupancy HCRIS84.2%
Revenue / Bed COMPUTED$711K
Net-to-Gross HCRIS93.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
46
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 61.3% places it above the state median. Among 46 size-comparable peers (61-244 beds), the median margin is 1.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (61-244), prioritizing same-state peers. 46 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UBH OF PHOENIX LLC DBA VALLEY (Target)AZ122$86.7M61.3%
BANNER GATEWAY MEDICAL CENTERAZ185$573.8M5.2%
FLAGSTAFF MEDICAL CENTERAZ242$477.9M-0.8%
YAVAPAI REGIONAL MEDICAL CENTEAZ218$456.9M-2.2%
MERCY GILBERT MEDICAL CENTERAZ197$381.9M6.3%
KINGMAN REGIONAL MEDICAL CENTEAZ196$373.6M-6.0%
HONORHEALTH DEER VALLEY MED CTAZ204$372.1M3.3%
ABRAZO WEST CAMPUSAZ207$303.3M22.2%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.8M+210bp18mo
Cost to Collect4.5%2.5%$1.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$55K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.8M
Cost to Collect
$1.7M
Denial Rate Reduction
$1.7M
A/R Days Reduction
$1.1M
Clean Claim Rate
$55K
Total EBITDA Uplift$6.4M
Current EBITDA$53.1M
+ RCM Uplift+$6.4M
Pro Forma EBITDA$59.5M
Current Margin61.3%
Pro Forma Margin68.6%
WC Released (1x)$3.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$81.7M$414.3M5.07x38.4%
Base (11x exit)10.0x11.0x$81.7M$482.2M5.90x42.6%
Bull Case9.0x11.0x$73.6M$529.9M7.20x48.4%
Bull (12x exit)9.0x12.0x$73.6M$599.7M8.15x52.1%
Bear Case11.0x10.0x$89.9M$355.8M3.96x31.7%
Bear (11x exit)11.0x11.0x$89.9M$420.6M4.68x36.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 46 hospitals with 61-244 beds
  • Same-state prioritization (n=47)
  • Comp margins: P25=-6.4% / P50=1.9% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.